查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
自行注射器市场:现状分析与预测(2022-2028年)
市场调查报告书
商品编码
1290905

自行注射器市场:现状分析与预测(2022-2028年)

Self-injection Devices Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 155 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于医疗保健领域越来越多地采用先进技术，预计自我注射器市场在预测期内将以 6% 的复合年增长率增长。例如，2022 年 5 月，Jabiru Healthcare 宣布推出 Qfinity(TM) 自动注射器平台，这是一种具有广泛适用性的可重复使用的药物输送设备。

为了更好地了解自动注射器行业的市场采用情况，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、意大利、西班牙、欧洲其他地区） ）、亚太地区（中国、日本、印度）、韩国、澳大利亚以及亚太地区其他地区）以及世界其他地区。2021年，由于老年人口不断增加以及老年人口疾病发生频率增加，自动注射器市场由北美主导。此外，该地区主要市场参与者的存在和完善的医疗基础设施归因于北美自动注射器市场的主要占有率。

目录

第1章 市场简介

  • 市场定义
  • 主要目的
  • 相关利益者
  • 限制事项

第2章 调查手法或前提

  • 调查流程
  • 调查手法
  • 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对全球自行注射器市场带来的影响

第6章 全球自行注射器的市场收益，2020-2028年

第7章 市场洞察:各产品

  • 自动注射器
  • 笔型注射器
  • 穿戴式注射器
  • 无针注射器

第8章 市场洞察:各可用性

  • 抛弃式
  • 可重复使用

第9章 市场洞察:各用途

  • 癌症
  • 自体免疫疾病
  • 荷尔蒙障碍
  • 疼痛管理
  • 其他

第10章 市场洞察:各地区

  • 北美的自行注射器市场
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲的自行注射器市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区的自行注射器市场
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • APAC的其他各国
  • 其他地区的自行注射器市场

第11章 自行注射器市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第12章 自行注射器市场机会

第13章 自行注射器市场趋势

第14章 需求面和供给面的分析

  • 需求面分析
  • 供给面分析

第15章 价值链分析

第16章 价格分析

第17章 策略性洞察能力

第18章 竞争模式

  • 竞争情形
    • 波特的五力分析

第19章 企业简介

  • Ypsomed AG
  • BD
  • Gerresheimer AG
  • Halozyme, Inc.
  • Haselmeier
  • NuGen Medical Devices
  • Owen Mumford Limited
  • SHL Medical AG
  • Pfizer Inc.
  • Amgen Inc.

第20章 免责声明

简介目录
Product Code: UMHE2118020

Self-injection devices are medical devices designed to allow patients to self-administer medications, such as insulin, growth hormones, and other biologics. These devices are typically used by patients who require regular injections and are designed to be easy to use, portable, and discreet. The growth of the market is mainly driven by the factors such as the increasing prevalence of chronic diseases requiring injectable treatments. For instance, as per the International Diabetes Federation, Approximately 537 million adults between 20 & 79 years are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

The Self-injection Devices Market is expected to grow at a strong CAGR of 6% during the forecast period owing to the increasing adoption of advanced technology in the healthcare sector. For instance, in May 2022, Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Reusable Drug Delivery Device with Broad Applicability.

Based on product, the market is segmented into autoinjectors, pen injectors, wearable injectors, and needle-free injectors. Pen injectors held dominating share in 2021. Pen injectors are medical devices that are used to deliver medication subcutaneously (under the skin) or intramuscularly (into the muscle). They consist of a pen-like device that contains a pre-filled cartridge or a replaceable insulin reservoir, and a needle that is attached to the end of the pen. The convenient usage of the self-injection of these devices, along with the increasing prevalence of chronic diseases attributes to the growth of the segment.

On the basis of usability, the market is bifurcated into disposable and reusable. The disposable segment held a significant share of the self-injection devices market in 2021. This is mainly due to the fact that disposable self-injection devices being sterile and designed for single use, which reduces the risk of infection or contamination. This is particularly important for patients who have compromised immune systems or are at higher risk for infection.

Based on application, the market is segmented into cancer, autoimmune disorders, hormonal disorders, pain management, and others. The cancer had the largest share in 2021 in the self-injection devices market. The higher prevalence of cancer is responsible for the increasing demand for self-injection devices. For instance, as per the National Cancer Institute, in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease.

For a better understanding of the market adoption of the self-injection devices industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America dominated the self-injection devices market in 2021 due to the rising geriatric population and increased frequency of diseases among them. Furthermore, the presence of major market players, along with the well-established healthcare infrastructure in the region attributed to the major share of the self-injection devices market in North America.

Some of the major players operating in the market include: Ypsomed AG; BD; Gerresheimer AG; Halozyme, Inc.; Haselmeier; NuGen Medical Devices; Owen Mumford Limited; SHL Medical AG; Pfizer Inc.; and Amgen Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Self-Injection Devices Market
  • 2.2. Research Methodology of the Self-Injection Devices Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL SELF-INJECTION DEVICES MARKET COVID-19 IMPACT

6 GLOBAL SELF-INJECTION DEVICES MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCTS

  • 7.1. Autoinjectors
  • 7.2. Pen injectors
  • 7.3. Wearable injectors
  • 7.4. Needle-free injectors

8 MARKET INSIGHTS BY USABILITY

  • 8.1. Disposable
  • 8.2. Reusable

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Cancer
  • 9.2. Autoimmune disorders
  • 9.3. Hormonal disorders
  • 9.4. Pain management
  • 9.5. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Self-Injection Devices Market
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Self-Injection Devices Market
    • 10.2.1. Germany
    • 10.2.2. UK
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific Self-Injection Devices Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of APAC
  • 10.4. Rest of the World Self-Injection Devices Market

11 SELF-INJECTION DEVICES MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 SELF-INJECTION DEVICES MARKET OPPORTUNITIES

13 SELF-INJECTION DEVICES MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1. Competitive Landscape
    • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

  • 19.1. Ypsomed AG
  • 19.2. BD
  • 19.3. Gerresheimer AG
  • 19.4. Halozyme, Inc.
  • 19.5. Haselmeier
  • 19.6. NuGen Medical Devices
  • 19.7. Owen Mumford Limited
  • 19.8. SHL Medical AG
  • 19.9. Pfizer Inc.
  • 19.10. Amgen Inc.

20 DISCLAIMER